Can nivolumab alone cure patients with relapse or refractory Hodgkin lymphoma? A 5-year analysis of the French early access program (EPA)

Manson, G., Herbaux, C., Schiano, J. M., Casasnovas, O., Stamatoullas, A., Deau, B., … Houot, R. (2022, July 1). Can nivolumab alone cure patients with relapse or refractory Hodgkin lymphoma? A 5-year analysis of the French early access program (EPA). British Journal of Haematology. John Wiley and Sons Inc. https://doi.org/10.1111/bjh.18198